Purple Biotech Ltd
PPBT0.602USD
+0.005+0.77%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
5.44MMarket Cap
LossP/E TTM
More Details of Purple Biotech Ltd Company
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd Info
Ticker SymbolPPBT
Company namePurple Biotech Ltd
IPO dateSep 03, 1978
CEOEfron (Gil)
Number of employees9
Security typeDepository Receipt
Fiscal year-endSep 03
Address4 Oppenheimer St.
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670104
Phone97239333121
Websitehttps://purple-biotech.com/
Ticker SymbolPPBT
IPO dateSep 03, 1978
CEOEfron (Gil)
Company Executives of Purple Biotech Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Mr. Ran Tzror
Mr. Ran Tzror
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Mr. Simcha Rock
Mr. Simcha Rock
Director
Director
--
--
Dr. Gil Ben-Menachem
Dr. Gil Ben-Menachem
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Ido Agmon
Mr. Ido Agmon
Independent Director
Independent Director
--
--
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Jan 31
Updated: Sat, Jan 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lincoln Alternative Strategies LLC
6.51%
Orca Capital GmbH
3.30%
Virtu Americas LLC
0.53%
Citadel Advisors LLC
0.44%
BNP Paribas Securities Corp. North America
0.12%
Other
89.10%
Shareholders
Shareholders
Proportion
Lincoln Alternative Strategies LLC
6.51%
Orca Capital GmbH
3.30%
Virtu Americas LLC
0.53%
Citadel Advisors LLC
0.44%
BNP Paribas Securities Corp. North America
0.12%
Other
89.10%
Shareholder Types
Shareholders
Proportion
Corporation
6.51%
Investment Advisor
3.35%
Research Firm
0.77%
Hedge Fund
0.44%
Investment Advisor/Hedge Fund
0.03%
Other
88.90%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
37
426.85K
4.59%
+179.97K
2025Q3
40
355.08K
3.82%
+98.77K
2025Q2
37
55.19K
1.82%
-201.60K
2025Q1
39
103.31K
6.70%
-153.87K
2024Q4
41
133.07K
5.02%
-58.34K
2024Q3
39
222.98K
11.78%
+111.64K
2024Q2
39
147.98K
8.71%
+1.90K
2024Q1
40
184.47K
11.90%
+40.99K
2023Q4
40
174.27K
11.63%
+106.33K
2023Q3
38
64.91K
3.14%
-5.47K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lincoln Alternative Strategies LLC
605.00K
6.51%
+605.00K
--
Sep 04, 2025
Orca Capital GmbH
306.39K
3.3%
+306.39K
--
Sep 07, 2025
Virtu Americas LLC
48.99K
0.53%
+48.99K
--
Sep 30, 2025
Citadel Advisors LLC
41.26K
0.44%
+41.26K
--
Sep 30, 2025
BNP Paribas Securities Corp. North America
11.28K
0.12%
+5.00K
+79.68%
Sep 30, 2025
Morgan Stanley & Co. LLC
11.06K
0.12%
+6.50K
+142.39%
Sep 30, 2025
UBS Financial Services, Inc.
5.95K
0.06%
-17.20K
-74.30%
Sep 30, 2025
GAMMA Investing LLC
2.84K
0.03%
-9.82K
-77.59%
Dec 31, 2025
Rhumbline Advisers Ltd. Partnership
1.08K
0.01%
--
--
Sep 30, 2025
SBI Securities Co., Ltd.
20.00
0%
--
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
